C176H365F2N21O9 — CID 159652068
1-tert-butyl-3,3-difluoropyrrolidine;4-tert-butyl-2,6-dimethylmorpholine;1-tert-butyl-2,5-dimethylpyrrolidine;1-tert-butyl-3-ethylpiperidine;1-tert-butyl-2-ethylpyrrolidine;1-tert-butyl-4-methylpiperazine;1-tert-butyl-2-methylpiperidine;1-tert-butyl-3-methylpiperidine;1-tert-butyl-2-methylpyrrolidine;4-tert-butylmorpholine;4-tert-butylpiperazin-2-one;1-tert-butylpiperidine;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;(1-tert-butylpiperidin-2-yl)methanol;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-3-ol;bis(1-(1-tert-butylpyrrolidin-2-yl)ethanone) (PubChem CID 159652068) has the molecular formula C176H365F2N21O9 and a molecular weight of 2957.99 g/mol. Its IUPAC name is 1-tert-butyl-3,3-difluoropyrrolidine;4-tert-butyl-2,6-dimethylmorpholine;1-tert-butyl-2,5-dimethylpyrrolidine;1-tert-butyl-3-ethylpiperidine;1-tert-butyl-2-ethylpyrrolidine;1-tert-butyl-4-methylpiperazine;1-tert-butyl-2-methylpiperidine;1-tert-butyl-3-methylpiperidine;1-tert-butyl-2-methylpyrrolidine;4-tert-butylmorpholine;4-tert-butylpiperazin-2-one;1-tert-butylpiperidine;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;(1-tert-butylpiperidin-2-yl)methanol;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-3-ol;bis(1-(1-tert-butylpyrrolidin-2-yl)ethanone).
| Compound Name | 1-tert-butyl-3,3-difluoropyrrolidine;4-tert-butyl-2,6-dimethylmorpholine;1-tert-butyl-2,5-dimethylpyrrolidine;1-tert-butyl-3-ethylpiperidine;1-tert-butyl-2-ethylpyrrolidine;1-tert-butyl-4-methylpiperazine;1-tert-butyl-2-methylpiperidine;1-tert-butyl-3-methylpiperidine;1-tert-butyl-2-methylpyrrolidine;4-tert-butylmorpholine;4-tert-butylpiperazin-2-one;1-tert-butylpiperidine;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;(1-tert-butylpiperidin-2-yl)methanol;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-3-ol;bis(1-(1-tert-butylpyrrolidin-2-yl)ethanone) |
|---|---|
| PubChem CID | 159652068 |
| Molecular Formula | C176H365F2N21O9 |
| Molecular Weight | 2957.99 g/mol |
| Exact Mass | 2955.87 |
| IUPAC Name | 1-tert-butyl-3,3-difluoropyrrolidine;4-tert-butyl-2,6-dimethylmorpholine;1-tert-butyl-2,5-dimethylpyrrolidine;1-tert-butyl-3-ethylpiperidine;1-tert-butyl-2-ethylpyrrolidine;1-tert-butyl-4-methylpiperazine;1-tert-butyl-2-methylpiperidine;1-tert-butyl-3-methylpiperidine;1-tert-butyl-2-methylpyrrolidine;4-tert-butylmorpholine;4-tert-butylpiperazin-2-one;1-tert-butylpiperidine;1-tert-butylpiperidin-3-ol;1-tert-butylpiperidin-4-ol;(1-tert-butylpiperidin-2-yl)methanol;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-3-ol;bis(1-(1-tert-butylpyrrolidin-2-yl)ethanone) |
| SMILES | CC(=O)C1CCCN1C(C)(C)C.CC(=O)C1CCCN1C(C)(C)C.CC(C)(C)N1CCC(F)(F)C1.CC(C)(C)N1CCC(O)C1.CC(C)(C)N1CCC(O)CC1.CC(C)(C)N1CCCC(O)C1.CC(C)(C)N1CCCC1.CC(C)(C)N1CCCCC1.CC(C)(C)N1CCCCC1CO.CC(C)(C)N1CCNC(=O)C1.CC(C)(C)N1CCOCC1.CC1CCC(C)N1C(C)(C)C.CC1CCCCN1C(C)(C)C.CC1CCCN(C(C)(C)C)C1.CC1CCCN1C(C)(C)C.CC1CN(C(C)(C)C)CC(C)O1.CCC1CCCN(C(C)(C)C)C1.CCC1CCCN1C(C)(C)C.CN1CCN(C(C)(C)C)CC1 |
| InChI | InChI=1S/C11H23N.C10H21NO.2C10H19NO.C10H21NO.4C10H21N.C9H20N2.2C9H19NO.2C9H19N.C8H15F2N.C8H16N2O.2C8H17NO.C8H17N/c1-5-10-7-6-8-12(9-10)11(2,3)4;1-8-6-11(10(3,4)5)7-9(2)12-8;2*1-8(12)9-6-5-7-11(9)10(2,3)4;1-10(2,3)11-7-5-4-6-9(11)8-12;1-8-6-7-9(2)11(8)10(3,4)5;1-9-6-5-7-11(8-9)10(2,3)4;1-9-7-5-6-8-11(9)10(2,3)4;1-5-9-7-6-8-11(9)10(2,3)4;1-9(2,3)11-7-5-10(4)6-8-11;1-9(2,3)10-6-4-8(11)5-7-10;1-9(2,3)10-6-4-5-8(11)7-10;1-8-6-5-7-10(8)9(2,3)4;1-9(2,3)10-7-5-4-6-8-10;1-7(2,3)11-5-4-8(9,10)6-11;1-8(2,3)10-5-4-9-7(11)6-10;1-8(2,3)9-4-6-10-7-5-9;1-8(2,3)9-5-4-7(10)6-9;1-8(2,3)9-6-4-5-7-9/h10H,5-9H2,1-4H3;8-9H,6-7H2,1-5H3;2*9H,5-7H2,1-4H3;9,12H,4-8H2,1-3H3;8-9H,6-7H2,1-5H3;3*9H,5-8H2,1-4H3;5-8H2,1-4H3;2*8,11H,4-7H2,1-3H3;8H,5-7H2,1-4H3;4-8H2,1-3H3;4-6H2,1-3H3;4-6H2,1-3H3,(H,9,11);4-7H2,1-3H3;7,10H,4-6H2,1-3H3;4-7H2,1-3H3 |
| InChIKey | MRRSJCLUHFZWJC-UHFFFAOYSA-N |
| XLogP | 34.85 |
| TPSA | 227.42 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 208 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2957.99 |
| LogP ≤ 5 | 34.85 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 29 |